Search

Your search keyword '"Wach, S"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Wach, S" Remove constraint Author: "Wach, S" Publisher elsevier bv Remove constraint Publisher: elsevier bv
29 results on '"Wach, S"'

Search Results

2. Heterogeneity-analysis of molecular subtypes of muscle-invasive bladder cancer and their precursor lesions in multiregion mapped whole-organ bladders

3. Bladder tumor subtype commitment occurs in carcinoma in-situ driven by key signaling pathways including ECM remodeling

4. Heterogeneity-analysis of molecular subtypes of muscle-invasive bladder cancer and their precursor lesions in multiregion mapped whole-organ bladders

6. Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting

7. Comparative analysis of tumour mutational burden (TMB) prediction methods and its association with determinants of the tumour immune microenvironment of urothelial bladder cancer (UBC)

8. Prognostic role of FGFR Mutations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second-line setting

9. Efficacy of anti-PD(L)1 treatment in patients with metastatic urothelial cancer based on mRNA- and protein- based PD-L1 determination: Results from the multicentric, retrospective FOsMIC trial

10. Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes

11. Cytotoxic T cell related gene expression signature predicts improved outcome in muscle-invasive urothelial bladder cancer patients following radical cystectomy and adjuvant chemotherapy

12. Performance of FDA/EMA approved PD-L1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

14. Prognostic impact of tumor infiltrating lymphocytes and immune cell related gene expression after radical cystectomy in muscle-invasive bladder cancer

17. Prognostic impact of a 12-gene progression score in non-muscle invasive bladder cancer: A prospective multicenter validation study

18. 785 Neuropilin-2 and VEGF-C are independent prognostic factors for bladder cancer patients treated with transurethral resection and radiochemotherapy

21. A new cylindrical phantom for eye lens dosimetry development

28. The Immune Landscape of Cancer

29. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

Catalog

Books, media, physical & digital resources